Tag: and Padmanee Sharma

Curis, Inc. Announces 2021 Virtual Symposium: “VISTA: A New Immune Checkpoint in Cancer, Autoimmunity and Beyond”

Curis, Inc. (NASDAQ: CRIS), a biotechnology company focused on the development of innovative therapeutics for the treatment of cancer, today announced the virtual symposium, “VISTA: A New Immune Checkpoint in Cancer, Autoimmunity and Beyond,” taking place on June 18, 2021, 9:00-1:15 PM ET. Leaders in immunology across industry and academia will gather to discuss emerging checkpoint molecule, VISTA, including its function, the role it… Read more »